Your session is about to expire
← Back to Search
Membrane Sweeping for Pregnancy
Study Summary
This trial will help researchers understand if a common medical intervention to help induce labor is effective.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
- I currently have an infection in my cervix.I have experienced bleeding in the last part of my pregnancy.I have diabetes that started before or during my pregnancy.I currently have an active genital herpes infection.I have long-term high blood pressure or had it during pregnancy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To whom does this experimental medication trial apply?
"Accepted patients for this clinical trial should have a rupture and be between 18-50 years old. Up to 300 total participants will be accepted."
Are there any vacancies in this study for new participants?
"This specific trial is not looking for any more participants at this time, however that information was last updated in 2006. There are currently 180 other trials on clinicaltrials.gov that are actively recruiting people if you're interested."
For this clinical research, are elderly patients being sought?
"This trial is open to people aged 18-50, as outlined in the inclusion criteria."
What are the risks associated with this particular treatment plan?
"The safety of this treatment is estimated to be a 3. This assessment is based on the fact that this is a Phase 3 trial, which means that there is some evidence supporting the efficacy of the treatment as well as multiple rounds of data indicating that the treatment is safe."
Share this study with friends
Copy Link
Messenger